| Literature DB >> 33758424 |
Yoon Keun Cho1, Yeonho Son1, Abhirup Saha1, Doeun Kim2, Cheoljun Choi1, Minsu Kim1, Ji-Hyun Park1, Hyeonyeong Im1, Juhyeong Han1, Kyungmin Kim1, Young-Suk Jung3, Jeanho Yun4, Eun Ju Bae5, Je Kyung Seong6, Mi-Ock Lee1, Sangkyu Lee2, James G Granneman7,8, Yun-Hee Lee9,10.
Abstract
Obesity reduces adipocyte mitochondrial function, and expanding adipocyte oxidative capacity is an emerging strategy to improve systemic metabolism. Here, we report that serine/threonine-protein kinase 3 (STK3) and STK4 are key physiological suppressors of mitochondrial capacity in brown, beige and white adipose tissues. Levels of STK3 and STK4, kinases in the Hippo signalling pathway, are greater in white than brown adipose tissues, and levels in brown adipose tissue are suppressed by cold exposure and greatly elevated by surgical denervation. Genetic inactivation of Stk3 and Stk4 increases mitochondrial mass and function, stabilizes uncoupling protein 1 in beige adipose tissue and confers resistance to metabolic dysfunction induced by high-fat diet feeding. Mechanistically, STK3 and STK4 increase adipocyte mitophagy in part by regulating the phosphorylation and dimerization status of the mitophagy receptor BNIP3. STK3 and STK4 expression levels are elevated in human obesity, and pharmacological inhibition improves metabolic profiles in a mouse model of obesity, suggesting STK3 and STK4 as potential targets for treating obesity-related diseases.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33758424 DOI: 10.1038/s42255-021-00362-2
Source DB: PubMed Journal: Nat Metab ISSN: 2522-5812